<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="50324">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01973829</url>
  </required_header>
  <id_info>
    <org_study_id>12-007998</org_study_id>
    <nct_id>NCT01973829</nct_id>
  </id_info>
  <brief_title>The Checklist for Early Recognition and Treatment of Acute Illness (CERTAIN)</brief_title>
  <official_title>The Checklist for Early Recognition and Treatment of Acute Illness (CERTAIN)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to test whether the health care provider access and training in
      CERTAIN (Checklist for Early Recognition and Treatment of Acute Illness), would facilitate
      timely and error free best-practice delivery and minimize preventable death and costly
      complications in critically ill patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Adherence to best critical care practices</measure>
    <time_frame>Participants will be followed for the duration of ICU stay, an expected average of 2 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Adherence to best practice in initial evaluation and treatment of critically ill medical and surgical patients Appropriate shock resuscitation Appropriate sepsis treatment Appropriate mechanical ventilation Appropriate peptic ulcer, deep vein thrombosis and infectious disease prophylaxis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ICU and hospital lengths of stay</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patient will be followed till they get discharged from hospital for whatever length they stay.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality for 4 weeks</measure>
    <time_frame>Participants will be followed for the duration of 4 weeks and hospital discharge (up to 10 weeks post discharge)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patient will be followed for 4 weeks and hospital discharge(up to total 10 weeks post discharge)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Critical Illness</condition>
  <condition>Sepsis</condition>
  <condition>Respiratory Failure</condition>
  <condition>Shock</condition>
  <condition>Coma</condition>
  <condition>Bleeding</condition>
  <condition>Trauma</condition>
  <arm_group>
    <arm_group_label>Baseline arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Baseline data collection (3 months or 50 patients per ICU)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Checklist for Early Recognition and Treatment of Acute Illness (CERTAIN)</intervention_name>
    <description>This study is about training and implementation of best critical care practices in the international ICUs with variable resources facilitated by access to a specifically designed electronic checklist</description>
    <arm_group_label>Baseline arm</arm_group_label>
    <other_name>Checklist</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion:

        All adult (≥ 18 years) patients admitted for the first time to the participating ICUs will
        be included.

        Exclusion:

        Not critically Ill, admitted for low risk monitoring, planned ICU admissions for routine
        postoperative surveillance for less than 24 hours after uncomplicated surgery, readmission
        and transferred from outside ICU.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ognjen Gajic, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marija Kojicic, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute for Pulmonary Diseases, Novi Sad, Serbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rahul Kashyap, MD</last_name>
    <role>Study Director</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marcus Schultz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VU University of Amsterdam</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michelle N Gong, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montefiore Medical Center, New York USA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Oguz Kilickaya, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gulhane Military Medical Faculty, Ankara, Turkey</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Neill Adhikari, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Toronto, Toronto Canada</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Linda Bucher, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>College of Health Sciences, University of Delavere, Delawere USA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Daniel Talmor, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beth Israel Deakoness Medical Center, Boston USA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Guang An Men Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhao Xin, MD</last_name>
      <email>echo0111@sina.com</email>
    </contact>
    <investigator>
      <last_name>Zhao Xin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro De Diagnostica Imagenes Medicina Avanzada y Telemedicina CEDIMAT</name>
      <address>
        <city>Santo Domingo</city>
        <country>Dominican Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rafael Tolentino</last_name>
      <email>rtolentino@cedimat.net</email>
    </contact>
    <investigator>
      <last_name>Rafael Tolentino, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ispat General Hospital</name>
      <address>
        <city>Rourkela</city>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rajyabardhan Pattnaik, MD</last_name>
      <email>rajyabardhan@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Rajyabardhan Pattnaik, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ)</name>
      <address>
        <city>Mexico City</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Central State University Hospital</name>
      <address>
        <city>Ulaanbaatar</city>
        <country>Mongolia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Military Medical Academy</name>
      <address>
        <city>Belgrade</city>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maja Surbatovic, MD</last_name>
      <email>maja.surbatovic@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Maja Surbatovic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical center of Vojvodina</name>
      <address>
        <city>Novi Sad</city>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Institute for pulmonary diseases of Vojvodina</name>
      <address>
        <city>Sremska Kamenica</city>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marija Vukoja, MD</last_name>
      <email>kojicic.marija@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Jovan Matijasevic, MD</last_name>
      <email>jovanmat99@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Marija Vukoja, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>International hospital Kampala</name>
      <address>
        <city>Kampala</city>
        <country>Uganda</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>China</country>
    <country>Dominican Republic</country>
    <country>India</country>
    <country>Mexico</country>
    <country>Mongolia</country>
    <country>Serbia</country>
    <country>Uganda</country>
  </location_countries>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <link>
    <url>http://icertain.org/</url>
    <description>education and introduction website</description>
  </link>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 5, 2014</lastchanged_date>
  <firstreceived_date>October 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Ognjen Gajic</investigator_full_name>
    <investigator_title>CONS-CRITICAL CARE</investigator_title>
  </responsible_party>
  <keyword>CERTAIN, Checklist, ICU, Outcome, Adults</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Shock</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
